Sunday, October 13, 2024 from 2:15 PM to 3:45 PM MST at Convention Center North Building / North Ballroom 120A
Available for 1.50 hours of CPE creditActivity Number: 0217-0000-24-114-L01-PActivity Type: An Application-Based ActivityThis educational session will focus on transitions of care challenges for the general medicine practitioner. Specific topics will include 1) Inpatient to outpatient anticoagulation concerns, including access, monitoring, and overlap of medications; 2) Changes in inpatient to outpatient diabetes management, including the role of oral antihyperglycemic medications in the inpatient setting, steroid induced hyperglycemia, and the inpatient use of outpatient diabetes technologies; and 3) Challenges and changes in the management of pain and opioid use disorder, including the impact of DEA X and DATA 2000 waiver changes and the expanded inpatient management of opioid use disorder. The purpose of this session is to update adult medicine practitioners on current best practices in transitions of care pertaining to select high-risk medication classes and disease states including diabetes, anticoagulation, and pain that may impact patients in the non-ICU inpatient and outpatient settings.
Learning Objectives1. Analyze the impact of anticoagulation transitions in various healthcare settings, such as ambulatory oral anticoagulant use and subsequent inpatient transitions.
2. Formulate a plan to overcome barriers to transitions of care for patients on anticoagulation.
3. Examine common diabetes-related transition of care topics, including changes in inpatient to outpatient diabetes management, and steroid induced hyperglycemia.
4. Examine the inpatient use of outpatient diabetes technologies and implement strategies to minimize or prevent medication and/or technology errors that commonly occur in transitions of care for patients with diabetes.
5. Review legislative changes to opioid use disorder treatment, including DATA 2000 and elimination of requirements.
6. Design a treatment plan for opioid withdrawal and pain management in patients with opioid use disorder, with emphasis on how this affects transitions of care.
 | | Moderator: | Jordan A. (Perrine) Fuller, Pharm.D., MBA, BCCCP, BCPS |
|
Transitions of Care in Anticoagulation2:15 PM to 2:45 PM | | Speaker: | Toby C. Trujillo, Pharm.D., FCCP, FAHA, BCPS | | Professor of Clinical Pharmacy
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado | | View Biography |
|
|
Transitions of Care in Diabetes2:45 PM to 3:15 PM | | Speaker: | Jennifer N. Clements, Pharm.D., FCCP, BCACP, BCPS, BC-ADM, CDCES | | Clinical Professor and Director of Pharmacy Education
University of South Carolina College of Pharmacy
Greenville, South Carolina | | View Biography |
|
|
Transitions of Care in Pain and Opioid Use3:15 PM to 3:45 PM | | Speaker: | Lyndsi K. Meyenburg, Pharm.D., BCPS | | Clinical Pharmacy Specialist
Ascension Seton
Austin, Texas | | View Biography |
|
|